Inhibition of select mitochondrial enzymes in PC12 cells exposed to S-(1,1,2,2-tetrafluoroethyl)-L-cysteine

Biochemical Pharmacology

Volumn 58, Issue 10, 1999, Pages 1557-1565

  Park, Larry C H ^a,b   Gibson, Gary E ^a,b   Bunik, Victoria ^c   Cooper, Arthur J L ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b BURKE MEDICAL RESEARCH INSTITUTE   (United States)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Ketoglutarate dehydrogenase complex; Cysteine S conjugates; Halogenated xenobiotics; PC12 cells; Pyruvate dehydrogenase complex; S (1,1,2,2 tetrafluoroethyl) L cysteine

Indexed keywords

CYSTEINE CONJUGATE; GLYCERALDEHYDE 3 PHOSPHATE; HALIDE; MITOCHONDRIAL ENZYME; OXOGLUTARATE DEHYDROGENASE; PYRUVATE DEHYDROGENASE COMPLEX;

ARTICLE; CELL STRAIN; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME INHIBITION; MITOCHONDRION; PRIORITY JOURNAL; TOXICITY TESTING; XENOBIOTIC METABOLISM;

ANIMALS; CARBON-SULFUR LYASES; CYSTEINE; ENERGY METABOLISM; ENZYME INHIBITORS; HYDROCARBONS, FLUORINATED; KETOGLUTARATE DEHYDROGENASE COMPLEX; MITOCHONDRIA, HEART; PC12 CELLS; PYRUVATE DEHYDROGENASE COMPLEX; RATS; TRANSAMINASES;

EID: 0032879644     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(99)00247-6     Document Type: Article

References (46)

1. Koob M., Dekant W. Bioactivation of xenobiotics by formation of toxic glutathione conjugates. Chem Biol Interact. 77:1991;107-136.
2. Dekant W., Vamvakas S., Anders M.W. Formation and fate of nephrotoxic and cytotoxic glutathione S-conjugates Cysteine conjugate β-lyase pathway . Adv Pharmacol. 27:1994;115-162.
3. Cooper A.J.L., Tate S.S. Enzymes involved in processing glutathione conjugates. Sipes I.G., McQueen C.A., Gandolfi A.J., Guengerich F.P. Comprehensive Toxicology. Vol. 3:1998;329-363 Elsevier, Oxford.
4. Cooper A.J.L. Enzymology of cysteine S-conjugate β-lyases. Adv Pharmacol. 27:1994;71-113.
5. Nash J.A., King L.J., Lock E.A., Green T. The metabolism and disposition of hexachloro-1:3-butadiene in the rat and its relevance to nephrotoxicity. Toxicol Appl Pharmacol. 73:1984;124-137.
6. Lock E.A., Schnellmann R.G. The effect of haloalkene cysteine conjugates on rat renal glutathione reductase and lipoyl dehydrogense activities. Toxicol Appl Pharmacol. 104:1990;180-190.
7. Groves C.E., Schnellmann R.G., Sokol P.P., Steffens T.G., Lock A.E. Pentachlorobutadienyl-L-cysteine (PLBC) toxicity The importance of mitochondrial dysfunction . J Biochem Toxicol. 6:1991;253-260.
8. Kim H.S., Cha S.H., Abraham D.G., Cooper A.J.L., Endou H. Intranephron distribution of cysteine-S-conjugate β-lyase activity and its implication for hexachloro-1,3-butadiene-induced nephrotoxicity in rats. Arch Toxicol. 71:1997;131-141.
9. Jones T.W., Wallin A., Thor H., Gerdes R.G., Ormstad K., Orrenius S. The mechanism of pentachlorobutadienyl-glutathione nephrotoxicity studied with isolated rat renal epithelial cells. Arch Biochem Biophys. 251:1986;504-513.
10. Lash L.H., Anders M.W. Bioactivation and cytotoxicity of nephrotoxic amino acid and glutathione S-conjugates. Comments Toxicol. 1:1986;87-107.
11. Wallin A., Jones T.W., Vercesi A.E., Cotgreave I., Ormstad K., Orrenius S. Toxicity of S-pentachlorobutadienyl-L-cysteine studied with isolated rat renal cortical mitochondria. Arch Biochem Biophys. 258:1987;365-372.
12. Schnellmann R.G., Cross T.J., Lock E.A. Pentachlorobutadienyl-L-cysteine uncouples oxidative phosphorylation by dissipating the proton gradient. Toxicol Appl Pharmacol. 100:1989;498-505.
13. Vamvakas S., Sharma V.K., Shen S.S., Anders M.W. Perturbations of intracellular calcium distribution in kidney cells by nephrotoxic haloalkenyl cysteine S-conjugates. Mol Pharmacol. 38:1990;455-461.
14. 2+ and their association with cytotoxicity to renal cells. Biochem Pharmacol. 44:1992;1131-1138.
15. Stonard M.D., Parker V.H. 2-Oxoacid dehydrogenases of rat liver mitochondria as the site of action of S-(1,2-dichlorovinyl)-L-cysteine and S-(1,2-dichlorovinyl)-3-mercaptopropionic acid. Biochem Pharmacol. 20:1971;2417-2427.
16. Hayden P.J., Stevens J.L. Cysteine conjugate toxicity, metabolism and binding to macromolecules in isolated rat kidney mitochondria. Mol Pharmacol. 37:1990;468-476.
17. Bruschi S.A., West K.A., Crabb J.W., Gupta R.S., Stevens J.L. Mitochondrial HSP 60 (P1 protein) and a HSP70-like protein (mortalin) are major targets for modification during S-(1,1,2,2,2-tetrafluororethyl)-L-cysteine-induced toxicity. J Biol Chem. 268:1993;23157-23161.
18. Bruschi S.A., Lindsay J.G., Crabb J.W. Mitochondrial stress protein recognition of inactivated dehydrogenases during mammalian cell death. Proc Natl Acad Sci USA. 95:1998;13413-13418.
19. Cooper A.J.L., Abraham D.G., Gelbard A.S., Lai J.C.K., Petito C.K. High activities of glutamine transaminase K (dichlorovinylcysteine β-lyase) and ω-amidase in the choroid plexus of rat brain. J Neurochem. 61:1993;1731-1741.
20. Reichert D., Liebaldt G., Henschler D. Neurotoxic effects of dichloroacetylene. Arch Toxicol. 37:1967;23-38.
21. Greim H., Wolff T., Höffler M., Lahaniatis E. Formation of dichloroacetylene from trichloroethylene in the presence of alkaline material - Possible cause of intoxication after abundant use of trichloroethylene. Arch Toxicol. 56:1984;74-77.
22. Buxton P.H., Hayward M. Polyneuritis cranialis associated with industrial trichloroethylene poisoning. J Neurol Neurosurg Psychiatry. 30:1967;511-518.
23. Gibson G.E., Blass J.P. Inhibition of acetylcholine synthesis and of carbohydrate utilization by maple-syrup-urine disease metabolites. J Neurochem. 26:1976;1073-1078.
24. Gibson G.E., Sheu K.-F.R., Blass J.P., Baker A., Carlson K.C., Harding B., Perrino P. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer's disease. Arch Neurol. 45:1988;836-840.
25. Gibson G.E., Zhang H., Sheu K.-F.R., Bogdanovich N., Lindsay J.G., Lannfelt L., Vestling M., Cowburn R.F. α-Ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation. Ann Neurol. 44:1998;676-681.
26. Mizuno Y., Matsuda S., Yoshino H., Mori H., Hattori N., Ikebe S.I. An immunohistochemical study on α-ketoglutarate dehydrogenase complex in Parkinson's disease. Ann Neurol. 35:1994;204-210.
27. Mastrogiacomo F., Lindsay J.G., Bettendorff L., Rice J., Kish S.J. Brain protein and α-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. Ann Neurol. 39:1996;592-598.
28. Stanley C.J., Perham R.N. Purification of 2-oxoacid dehydrogenase multienzyme complexes from ox heart by a new method. Biochem J. 191:1980;147-154.
29. Bunik V., Follmann H. Thioredoxin reduction dependent on α-ketoacid oxidation by α-ketoacid dehydrogenase complexes. FEBS Lett. 336:1993;197-200.
30. Cooper A.J.L. Purification of soluble and mitochondrial glutamine transaminase K from rat kidney. Use of a sensitive assay involving transamination between l-phenylalanine and α-keto-γ-methiolbutyrate. Anal Biochem. 89:1978;451-460.
31. Kim K.S., Huang H.M., Zhang H., Wagner J., Joh T., Gibson G.E. The role of signal transduction systems in mediating cell density dependent changes in tyrosine hydroxylase gene expression. Brain Res Mol Brain Res. 33:1995;254-260.
32. Parli J.D., Godfrey D.A., Ross C.D. Separate microassays for aspartate aminotransferase isoenzymes. Biochim Biophys Acta. 925:1987;175-184.
33. Ksiezak-Reding H., Blass J.P., Gibson G.E. Studies on the pyruvate dehydrogenase complex in brain with arylamine acetyltransferase-coupled assay. J Neurochem. 38:1982;1627-1636.
34. Sheu K.-F.R., Hu C.W.C., Utter M.F. Pyruvate dehydrogenase complex in normal and deficient fibroblasts. J Clin Invest. 67:1981;1463-1471.
35. Likos J.J., Ueno H., Feldhaus R.W., Metzler D.E. A novel reaction of the coenzyme of glutamate decarboxylase with L-serine-O-sulfate. Biochemistry. 21:1982;4377-4386.
36. Chen Q., Jones T.W., Brown P.C., Stevens J.L. The mechanism of cysteine conjugate cytotoxicity in renal epithelial cells. J Biol Chem. 265:1990;21603-21611.
37. 4. J Biol Chem. 270:1995;180-188.
38. Kato Y., Asano Y., Cooper A.J.L. Inactivation of brain and kidney aspartate aminotransferases by S-(1,2-dichlorovinyl)-L-cysteine and by S-(1,1,2,2-tetrafluoroethyl)-L-cysteine. Dev Neurosci. 18:1996;505-514.
39. Ueno H., Likos J.J., Metzler D.E. Chemistry of the inactivation of cytosolic aspartate aminotransferase by serine O-sulfate. Biochemistry. 21:1982;4387-4393.
40. Westphal A.H., Fabisz-Kijowska A., Kester H., Obels P.P., De Kok A. The interaction between lipoamide dehydrogenase and the peripheral-component-binding domain from the Azotobacter vinelandii pyruvate dehydrogenase complex. Eur J Biochem. 234:1995;861-870.
41. McCartney R.G., Rice J.E., Sanderson S.J., Bunik V., Lindsay H., Lindsay J.G. Subunit interactions in the mammalian α-ketoglutarate dehydrogenase complex. Evidence for direct association of the α-ketoglutarate dehydrogenase and dihydrolipoamide dehydrogenase components. J Biol Chem. 237:1998;24159-24164.
42. Fitzpatrick S.M., Cooper A.J.L., Duffy T.E. Use of β-methylene-D,L-aspartate to assess the role of aspartate aminotransferase in cerebral oxidative metabolism. J Neurochem. 41:1983;1370-1383.
43. Humphries K.M., Szweda L.I. Selective inactivation of α-ketoglutarate dehydrogenase and pyruvate dehydrogenase Reaction of lipoic acid with 4-hydroxy-2-nonenal . Biochemistry. 37:1998;15835-15841.
44. Park L.C.H., Zhang H., Sheu K.-F.R., Calingasan N.Y., Kristal B.S., Lindsay J.G., Gibson G.E. Metabolic impairment induces oxidative stress, compromises inflammatory responses and inactivates a key mitochondrial enzyme in microglia. J Neurochem. 72:1999;1948-1958.
45. Mastrogiacomo F., Bergeron C., Kish S.J. Brain alpha-ketoglutarate dehydrogenase complex activity in Alzheimer's disease. J Neurochem. 61:1993;2007-2014.
46. Butterworth R.F., Kril J.J., Harper C.G. Thiamine-dependent enzyme changes in the brains of alcoholics Relationship to the Wernicke-Korsakoff syndrome . Alcohol Clin Exp Res. 71:1993;1084-1088.